Aritzia Inc (ATZ): UBS expects a solid Aritzia 2Q27 beat but limited earnings-event volatility

Overview

This earnings preview assesses whether Aritzia can sustain strong demand and margin momentum into fiscal 2Q27 and beyond. UBS expects a modest EPS beat and a solid 3Q outlook, but believes consensus already broadly anticipates this outcome, limiting the likelihood of a major share-price reaction around earnings.

Core views

UBS expects Aritzia to report fiscal 2Q27 EPS of C$1.09, C$0.05 above consensus, on sales of C$1.126 billion, up 38.6% year over year and 100 basis points above consensus growth. Its forecast assumes 30% comparable-sales growth, supported by 12 boutique openings and four repositions completed over the preceding 12 months. UBS expects retail sales to rise 39.1% to C$795 million and eCommerce sales to rise 37.4% to C$330 million; by region, it models US sales up 49% to C$724 million and Canadian sales up 23% to C$401 million. The report argues that underlying demand remains robust even though some indicators have moderated. Google searches rose 23% year over year in the US but decelerated by 4,250 basis points versus three months earlier, while Canadian searches fell 5% and decelerated by 765 basis points. In contrast, website unique visitors rose 71% in the US and 18% in Canada during 2Q, and US observed sales increased 58%, including 68% growth in June, 50% in July and 52% in August; 3Q-to-date observed sales were up 49%. UBS also notes that the mobile app exceeded 2 million downloads, represents a high-single-digit incremental contribution to digital sales and accounts for roughly 30% of digital revenue. These indicators, together with US square footage growth of 25% year over year in 1Q27 and store paybacks of less than one year, underpin the firm's sales forecast. Margins are a second pillar of the forecast. UBS projects 46.8% gross margin, up 300 basis points year over year, aided by disciplined inventories, lower markdowns, occupancy leverage and higher initial markups. Its pricing data show promotional discount factors declined by 930 basis points in the US and 255 basis points in Canada. UBS expects tariff pressure to moderate after an approximately 190-basis-point headwind in 1Q27 and views initial-markup execution, markdown intensity and distribution-center cost absorption as the principal margin swing factors. It forecasts SG&A of C$338 million, up 35.2%, but a 75-basis-point year-over-year SG&A rate improvement, producing C$188 million of EBIT, a 16.7% EBIT margin and approximately 375 basis points of operating-margin expansion. Continued investment in supply chain, digital systems, loyalty, AI, mobile and marketing may limit near-term conversion of gross-margin gains into operating-margin gains, although UBS sees these investments as future productivity enablers. For the earnings event, UBS expects management to reiterate FY27 revenue-growth and approximately 19.5% adjusted EBITDA-margin guidance because second-half comparisons become more difficult and management remains cautious. Its expected 3Q outlook calls for approximately 17-21% revenue growth, 11-13% comparable-sales growth, 75-125 basis points of gross-margin expansion and SG&A as a percentage of sales flat to down 50 basis points year over year. UBS considers the event hurdles to be a 2Q EPS beat with 29-30% comparable-sales growth, a solid 3Q outlook, and reaffirmation of FY27 sales and margin guidance. It raised its 2Q27 EPS estimate by C$0.01 to C$1.09 and lifted its FY27 sales-growth forecast by 20 basis points, but left FY27-FY29 EPS estimates unchanged. Positioning and valuation temper the near-term catalyst case. ATZ's crowding score of 6.5 exceeds the Softlines-peer average of 3.7 and its five-year average of 3.5, indicating relatively long-crowded positioning, although the stock has recently shown neither positive nor negative crowding momentum. ATZ trades at 20.0x FY2 P/E, a 48% premium to the broader Softlines group, down from 27.4x three months earlier amid concern over Canadian consumers and potentially slower 3Q comparisons after the prior-year mobile-app launch. Options price a +/-10.3% earnings move versus an 8.2% historical average; UBS expects less volatility than the historical average because its expected result and guidance reaffirmation largely match market expectations. UBS nevertheless maintains Buy and its C$216 target. The target applies an approximately 28x P/E multiple to C$7.80 FY29 EPS, a multiple UBS considers appropriate for the expected approximately 26% FY26-FY31 EPS CAGR; peer P/E, P/Sales and EV/EBITDA comparisons and a secondary DCF also support C$216. The base case assumes about 15% annual revenue growth, sustained 4-5% comparable-sales growth, operating margin rising to 23.5% in FY31 from 12.5% in FY25, 150 basis points of margin expansion and a 0.4% share-count reduction. UBS's upside case is C$288, based on approximately 31% five-year EPS CAGR and 32x P/E, while its downside case is C$74, assuming a deep US recession, weaker comparable sales, higher promotions, underperforming new stores and approximately 5% five-year EPS CAGR.

Analysis framework

UBS combines management commentary and company guidance with Evidence Lab search, traffic, pricing and store data, industry observed-sales data, consensus comparisons and forecast financial modelling. It then evaluates positioning and implied options volatility before applying peer multiples and a discounted cash flow cross-check to its target price.

Methodology notes

• Valuation methodsP/E and PEG Valuation

  Peer-multiple valuation using approximately 28x FY29 EPS.

  UBS applies a P/E multiple to its C$7.80 FY29 EPS estimate and compares Aritzia with peers on P/E, P/Sales and EV/EBITDA to derive the C$216 target.

• Valuation methodsDCF (Discounted Cash Flow)

  Discounted cash flow valuation as a secondary valuation method.

  UBS forecasts revenue, operating profit, tax, depreciation, capital expenditure and working capital to estimate free cash flow; its DCF cross-check also supports C$216.

• Other

  Quantitative crowding score and crowding momentum analysis.

  UBS uses positioning, changes in positioning and one-month relative momentum to identify long- or short-crowding risk around the earnings event.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Aritzia Inc (ATZ.TO)

  Primary covered company; UBS expects strong sales and margin momentum to support long-term earnings growth.

  Strengths

  Differentiated boutiques, US expansion, diversified product assortment, digital and mobile-app growth, strong customer engagement and lower promotional intensity.

  Weaknesses

  Near-term operating leverage is constrained by ongoing investment in distribution, digital, AI, marketing and new stores.

  Comparison

  ATZ's FY2 P/E of 20.0x implies a 48% premium to the broader Softlines group, though UBS states its C$216 target is within peer ranges on P/E, P/Sales and EV/EBITDA.

  Risks

  Comparable-sales deterioration could cause occupancy and labor-cost deleverage; US market-share gains may fail to materialize.

Key data

• 2Q27 EPS forecastC$1.09Up 85% year over year and C$0.05 above consensus.
• 2Q27 sales forecastC$1.126BUp 38.6% year over year; 100 basis points above consensus growth.
• 2Q27 comparable-sales forecast30%UBS expectation, versus management's high-20% outlook.
• 2Q27 gross margin forecast46.8%Up 300 basis points year over year.
• US observed-sales growth58% year over yearFiscal 2Q27; 3Q-to-date observed sales rose 49%.
• Crowding score6.5Above the Softlines-peer average of 3.7.
• Options-implied earnings move+/-10.3%Versus an 8.2% historical average move.
• Base-case target priceC$216Based on approximately 28x C$7.80 FY29 EPS; DCF is supportive.

Impact & implications

UBS sees evidence of strong demand and gross-margin improvement sufficient for a 2Q beat, but expects the company's prudent FY27 guidance posture and already-aligned market expectations to constrain the immediate earnings reaction. Its longer-term investment case rests on US store expansion, sustained comparable-sales growth, cost leverage, margin expansion and buybacks.

Risks

• Aritzia's aggressive store-expansion strategy could underperform if comparable sales weaken, causing occupancy and store-labor cost deleverage.
• Sales estimates rely on Aritzia gaining share in US women's apparel; if that gain does not materialize, sales could fall below expectations.
• UBS's downside scenario includes a deep US recession, weaker discretionary demand, increased promotions, inventory pressure and underperforming new stores.
• Near-term margin outcomes remain sensitive to initial-markup execution, markdown intensity and distribution-center cost absorption.

What to watch

• 2Q27 comparable-sales growth near the 29-30% threshold and whether EPS exceeds UBS's C$1.09 estimate.
• Fiscal 3Q27 guidance, including 11-13% comparable-sales growth, 75-125 basis points of gross-margin expansion and SG&A leverage.
• Whether management reaffirms FY27 revenue-growth and approximately 19.5% adjusted EBITDA-margin guidance.
• Consumer-demand trends in the US and Canada, including the impact of elevated gas prices.
• Supply-chain disruption and freight-cost effects from Middle East conflict, as well as tariff refunds and tariff-rate changes.
• Performance of new stores, including traffic, conversion, average basket size and store economics.